Cytosorbents Corporation Share Price

Cytosorbents Corporation Share Price

NASDAQ: CTSO | Micro Cap
$4.80
+$4.80 (--%) Last updated on 18 Nov, 2026 | 01:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cytosorbents Corporation Stock Performance

Open
$5.19
Prev. Close
N/A
Circuit Range
N/A
Day Range
$5.19 - $5.19
Year Range
$0.30 - $6.75
Volume
108
Average Traded
$5.19

Cytosorbents Corporation Share Price Chart

Line chart of the Cytosorbents Corporation price trend over the selected period. The price rose overall, ranging from 4.80 to 5.19, ending at 4.80.
$5.19$5.19
L
Show Current Price
H

Cytosorbents Corporation Stock Fundamentals & Key Indicators

Market Cap
$261.56M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.78
Revenue (TTM)
$37.06B
Return On Equity (TTM)
2425.17%
Profit Margin
-22.13%
Debt to Equity
-22.96
Quarterly Earnings Growth YoY
-39.43%

Cytosorbents Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$9.49$9.23$8.86$9.63
Net Profit-$3.17-$5.50-$5.13-$4.42
Net Profit Margin-33.40%-59.59%-57.90%-45.90%
Income ChangeN/A-73.50%6.73%13.84%

Cytosorbents Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$34.69$31.08$35.60$37.06
Net Profit-$32.81-$29.25-$20.72-$8.20
Net Profit Margin-94.58%-94.11%-58.20%-22.13%
Income ChangeN/A10.85%29.16%60.42%

About Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Cytosorbents Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.11
$5.19
+15.59%
Oct 2026
$4.25
$4.49
+9.25%
Sep 2026
$0.35
$4.11
+1,094.77%
Aug 2026
$0.37
$0.34
-13.78%
Jul 2026
$0.39
$0.40
+6.40%
Jun 2026
$0.47
$0.38
-23.47%
May 2026
$0.60
$0.49
-23.44%
Apr 2026
$0.56
$0.64
+12.28%
Mar 2026
$0.74
$0.57
-22.02%
Feb 2026
$0.67
$0.73
+15.66%
Jan 2026
$0.66
$0.63
+0.80%
Dec 2025
$0.82
$0.63
-24.09%

CTSO Share Price FAQs